FIL Ltd - WUXI PHARMATECH CAYMAN INC ownership

Quarter-by-quarter ownership
FIL Ltd ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$148,169,000
-42.0%
3,429,038
-43.2%
0.52%
-36.7%
Q2 2015$255,298,000
-5.7%
6,041,144
-13.4%
0.81%
-6.7%
Q1 2015$270,663,000
+13.1%
6,979,437
-1.8%
0.87%
+5.6%
Q4 2014$239,230,000
+15.2%
7,105,132
+19.8%
0.83%
+3.8%
Q3 2014$207,714,000
+46.6%
5,931,308
+37.5%
0.80%
+49.9%
Q2 2014$141,698,000
+0.9%
4,312,186
+14.1%
0.53%
+4.1%
Q1 2014$140,497,000
-26.2%
3,778,777
-23.9%
0.51%
-33.5%
Q4 2013$190,462,000
+12.6%
4,962,539
-19.6%
0.77%
-5.1%
Q3 2013$169,076,000
+25.4%
6,170,639
-3.9%
0.81%
+5.9%
Q2 2013$134,823,0006,420,1390.76%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders